EVs derived from prostate cancer and mesothelioma cell lines were shown by Webber et al49 to express transforming growth factor‐beta (TGF‐β), triggering the TGF‐β/SMAD3 pathway in fibroblasts allowing their differentiation into myofibroblastic phenotypes. Here, TGFB1 is linked to prostate cancer.